Financial research concept

Healthcare Distribution Segment Depreciation & Amortization

Healthcare distribution segment depreciation and amortization shows how McKesson's non-cash asset charges differ across pharmaceutical distribution, specialty care, prescription technology, and medical-surgical operations.

By Lee BaileyPublished Sep 24, 2026
Research context

See what supports this page, how current it is, and where comparable or historical context is available.

Research date
Sep 24, 2026Use the dated article and cited sources for the definition, examples, and stated limitations.
Operating-model context
15 connected conceptsPart of the reviewed Healthcare Distribution & Services Economics; issuer definitions remain distinct where disclosed.
Company examples
1 reviewed companyRelationships reflect supported examples, not a normalized cross-company KPI ranking.
  1. What it reveals
  2. Investor caution
  3. Part of the Healthcare Distribution & Services Economics
  4. See It in Company Research
  5. Continue Research

Healthcare distribution segment depreciation and amortization shows McKesson's reported D&A assigned across its reportable operating segments. For fiscal 2026, McKesson reported segment depreciation and amortization of $134 million for North American Pharmaceutical, $240 million for Oncology & Multispecialty, $82 million for Prescription Technology Solutions, and $96 million for Medical-Surgical Solutions.

What it reveals

D&A helps frame the asset burden behind each business model. It can be useful when comparing segment operating profit with the physical and acquired-asset base supporting distribution centers, technology platforms, provider businesses, and other long-lived assets.

Investor caution

Segment D&A is not capital expenditure, maintenance capital, or cash spending in the current period. It can include amortization of acquired intangible assets as well as depreciation, and acquisition history can make cross-segment comparisons noisy. Read it separately from segment long-lived asset expenditures.

Primary source: McKesson fiscal 2026 Form 10-K.

Part of the Healthcare Distribution & Services Economics

Connect pharmaceutical and medical distribution scale, specialty and prescription-technology profitability, service mix, and asset intensity to understand healthcare distribution and services economics.

How the model fits together
  • Core pharmaceutical distribution scale and margin: North American Pharmaceutical revenue shows the scale of McKesson's core distribution engine, while segment operating profit and margin show how a very large revenue base converts into segment earnings. Service revenue mix helps preserve the distinction between product-heavy distribution revenue and service-oriented economics.
  • Specialty care and prescription-technology economics: Oncology & Multispecialty and Prescription Technology Solutions pair revenue scale with segment profit and margin across specialty distribution, provider solutions, medication-access technology, and third-party logistics. Service revenue mix adds context for why these businesses can carry different economics without implying standardized peer margins.
  • Medical-surgical distribution and asset intensity: Medical-Surgical Solutions revenue, operating profit, and margin show the economics of non-acute distribution, while segment depreciation and amortization and long-lived-asset expenditures show different views of the asset base and current investment. Those capital measures are not interchangeable with each other or with total company capital expenditure.

See It in Company Research

These companies are examples of how the concept is reported or discussed in public filings. Definitions can differ by issuer; these links open company research rather than a normalized metric comparison.

Continue Research

Continue from the concept into the Grizzly Bulls research surface that best matches the next question. These links are research continuations, not recommendations or required steps.

Compare stocks

Compare healthcare distribution and services stocks

Continue into stock comparison after reviewing segment scale, profitability, service mix, and capital intensity across healthcare distribution and services businesses.

Continue research

Explore more topics in the Financial Research Encyclopedia.